Investors

EXPMARDS
All numbers in thousands USD
Period Ending
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Revenue
--
19,647
1,082
1,213
Cost of Revenue
--
--
--
(33,084)
Gross Profit
417
19,647
1,082
1,213
Operating Expenses
Research Development
175
4,668
(5,531)
7,007
Selling General and Administrative
1,111
1,310
--
1,626
Non Recurring
--
--
--
--
Others
0
0
(1,814)
0
Total Operating Expenses
1,286
5,978
(7,345)
8,633
Operating Income or Loss
(869)
13,669
6,613
(7,420)
Income from Continuing Operations
Total Other Income/Expenses Net
(26)
(26)
(25)
(25)
Earnings Before Interest And Taxes
(869)
13,698
6,665
(7,395)
Interest Expense
--
--
--
--
Income Before Tax
(842)
13,698
6,665
(7,249)
Income Tax Expense
--
--
--
(435)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(83)
12,144
6,665
(6,387)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(83)
12,144
6,665
(6,387)
Preferred Stock And Other Adjustments
(759)
1,554
605
--
Net Income Applicable To Common Shares
(83)
12,144
6,060
(6,387)